Genophenotypic factors and pharmacogenomics in adverse drug reactions

R Cacabelos, V Naidoo, L Corzo, N Cacabelos… - International journal of …, 2021 - mdpi.com
Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …

Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis

A Jena, DK Jha, P Kumar-M, KS Kasudhan… - Expert Review of …, 2021 - Taylor & Francis
Background: Prevalence and impact of thiopurine S-methyltransferase (TPMT) and Nudix
hydrolase (NUDT15) minor allele frequencies in South Asian population is unclear …

Reducing risk in thiopurine therapy

AM Marinaki, M Arenas-Hernandez - Xenobiotica, 2020 - Taylor & Francis
The thiopurine drugs azathioprine and mercaptopurine are effective in the treatment of
disorders of immune regulation and acute lymphoblastic leukaemia. Although developed in …

Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia

D Maamari, H El-Khoury, O Saifi… - Pharmacogenomics …, 2020 - Taylor & Francis
Despite major advances in the management and high cure rates of childhood acute
lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities …

Pharmacogenomics in Lebanon: current status, challenges and opportunities

L Chidiac, H Yazbeck, R Mahfouz… - The Pharmacogenomics …, 2024 - nature.com
Pharmacogenomics (PGx) research and applications are of utmost relevance in Lebanon
considering its population genetic diversity. Moreover, as a country with regional leadership …

Pharmacogenomics in pediatric oncology: mitigating adverse drug reactions while preserving efficacy

AA Elzagallaai, BC Carleton… - Annual review of …, 2021 - annualreviews.org
Cancer is the leading cause of death in American children older than 1 year of age. Major
developments in drugs such as thiopurines and optimization in clinical trial protocols for …

Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising “MINT” sequencing strategy and therapeutic “DNA-TG” monitoring

HL Guo, YT Zhao, WJ Wang, N Dong, YH Hu… - Frontiers in …, 2022 - frontiersin.org
Thiopurines, including thioguanine (TG), 6-mercaptopurine (6-MP), and azathioprine (AZA),
are extensively used in clinical practice in children with acute lymphoblastic leukemia (ALL) …

Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants

DS Wang, CH Yu, CY Lin, YH Chang, KH Lin… - Pediatric …, 2021 - nature.com
Background Mercaptopurine-induced neutropenia can interrupt chemotherapy and expose
patients to infection during childhood acute lymphoblastic leukemia (ALL) treatment …

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China

X Mao, R Yin, G Sun, Y Zhou, C Yang, C Fang… - Frontiers in …, 2021 - frontiersin.org
Background: 6-Mercaptopurine (6-MP) is the cornerstone of current antileukemia regimen
and contributes greatly to improve the survival of pediatric acute lymphoblastic leukemia …

Effect of ITPA polymorphism on adverse drug reactions of 6-mercaptopurine in pediatric patients with acute lymphoblastic leukemia: a systematic review and meta …

Y Lee, EJ Jang, HY Yoon, J Yee, HS Gwak - Pharmaceuticals, 2022 - mdpi.com
6-Mercaptopurine (6-MP) is a cornerstone of the maintenance regimen for pediatric acute
lymphoblastic leukemia (ALL). Inosine triphosphate pyrophosphatase (ITPA) is considered a …